First Dallas Securities’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$83.8K Hold
10,000
– – 0.03% 119
2026
Q2
$57.7K Hold
10,000
– – 0.02% 124
2026
Q1
$49.5K Buy
+10,000
New +$48.7K 0.02% 117

Other funds holding SOPH

First Dallas Securities's SOPH Position: Q3 2026 in Review

First Dallas Securities held its SOPHiA GENETICS (SOPH) position steady in Q3 2026 at 10,000 shares worth $83.8K. The position accounts for 0.03% of the portfolio, ranked #119.

First Dallas Securities first reported a position in SOPH in Q1 2026 and has held it in 3 quarters since. 69 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

  • First Dallas Securities held 10,000 shares of SOPHiA GENETICS worth $83.8K as of Q3 2026.
  • First Dallas Securities left its SOPHiA GENETICS share count unchanged in Q3 2026.
  • SOPHiA GENETICS made up 0.03% of First Dallas Securities's portfolio in Q3 2026, its #119 holding.
  • First Dallas Securities first reported a position in SOPHiA GENETICS in Q1 2026 and has held it in 3 quarters since.
  • 69 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on First Dallas Securities's 13F filing for Q3 2026, filed 13 Nov 2026.